Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · February 24, 2021

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

JAMA Oncology

 

Additional Info

JAMA Oncology
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
JAMA Oncol 2021 Feb 11;[EPub Ahead of Print], FY Feng, HC Huang, DE Spratt, SG Zhao, HM Sandler, JP Simko, E Davicioni, PL Nguyen, A Pollack, JA Efstathiou, AP Dicker, T Todorovic, J Margrave, YS Liu, B Dabbas, DJS Thompson, R Das, JJ Dignam, C Sweeney, G Attard, JP Bahary, HR Lukka, WA Hall, TM Pisansky, AB Shah, SL Pugh, WU Shipley, PT Tran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading